Followers | 63 |
Posts | 4006 |
Boards Moderated | 0 |
Alias Born | 03/25/2011 |

Tuesday, December 17, 2024 10:25:56 AM

Recent QTTB News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/25/2025 12:05:35 PM
- Q32 Bio Appoints Adrien Sipos, M.D., Ph.D., as Interim Chief Medical Officer • PR Newswire (US) • 06/25/2025 10:59:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2025 08:02:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2025 11:11:49 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2025 11:05:31 AM
- Q32 Bio Reports First Quarter 2025 Financial Results and Provides Corporate Update • PR Newswire (US) • 05/08/2025 10:59:00 AM
- Q32 Bio Announces FDA Fast Track Designation Granted to Bempikibart (ADX-914) for the Treatment of Alopecia Areata • PR Newswire (US) • 04/30/2025 10:59:00 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/29/2025 11:19:46 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/29/2025 11:15:34 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/29/2025 11:10:41 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/25/2025 08:02:20 PM
- Q32 Bio Doses First Patients in Both Part A Open-Label Extension and Part B of SIGNAL-AA Phase 2a Trial Evaluating Bempikibart in Alopecia Areata • PR Newswire (US) • 04/16/2025 10:59:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/11/2025 12:15:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/11/2025 11:24:41 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/11/2025 11:18:16 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2025 11:03:36 AM
- Q32 Bio Reports Fourth Quarter 2024 Financial Results and Provides Corporate Update • PR Newswire (US) • 03/11/2025 10:59:00 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/10/2025 11:05:48 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2025 11:00:20 AM
- Q32 Bio Presents Results from SIGNAL-AA Part A Clinical Trial Evaluating Bempikibart in Patients with Alopecia Areata at the 2025 American Academy of Dermatology Meeting • PR Newswire (US) • 03/08/2025 04:00:00 PM
- Q32 Bio Announces Late-Breaking Presentation of Results from SIGNAL-AA Part A Clinical Trial of Bempikibart in Alopecia Areata at the 2025 American Academy of Dermatology Annual Meeting • PR Newswire (US) • 02/28/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2025 02:59:00 AM
A New Mining Model Is Emerging - And Wall Street Is Paying Attention • B • Jul 15, 2025 9:00 AM
Sanwire Files Complaint Against Intercept Music and Trillium Partners • SNWR • Jul 15, 2025 9:00 AM
Cannabix Technologies Commences First Production of BreathLogix Alcohol Screening Devices • BLO • Jul 15, 2025 8:47 AM
Nightfood's FHVH to Pioneer AI-Driven Culinary Education in $32.5 Billion US Market • NGTF • Jul 15, 2025 8:30 AM
The Crypto Company (OTC: CRCW) Joins New OTCID Market Tier, Marking Commitment to Innovation, Transparency, and Strategic Growth • CRCW • Jul 15, 2025 8:19 AM
Avant Technologies and JV Partner, Ainnova, Complete Pivotal Meeting with U.S. FDA • AVAI • Jul 15, 2025 8:00 AM